Get Help Now

Contact a Lawyer in
North or South Carolina.

Taxotere® Chemotherapy and Permanent Hair Loss

More American women are diagnosed with breast cancer than any other type of cancer. A majority of these patients choose to undergo chemotherapy treatment, which commonly includes an injectable drug called Taxotere®. During treatment, doctors inform patients of the uncomfortable side effects they can expect, such as temporary hair loss. However, some cancer survivors treated with Taxotere are experiencing a side effect they weren’t prepared for—permanent significant alopecia.

If you or your loved one were diagnosed with Stage 1, 2, or 3 cancers after 2005 and suffered permanent hair loss after undergoing chemotherapy, Crumley Roberts wants to stand up for you. Our lawyers understand how tough cancer survivors have to be to get to remission, and we think Taxotere patients facing permanent hair loss have gone through enough already.

Permanent alopecia impacts your self-esteem, body image, and quality of life. We’ll fight to help you get the compensation you deserve for your Taxotere hair loss. Contact Crumley Roberts 24/7 to get started now—just dial 866-336-4547 or complete our free initial consultation form.

Study Links Taxotere® to Permanent Alopecia

One of the most traumatizing physical side effects of chemotherapy is hair loss. Patients are told to expect it before treatment starts—but they’re also told they can expect hair to grow back within 3-6 months after chemotherapy is complete. Yet since the mid-2000s, breast cancer survivors have reported permanent hair loss in increasing numbers.

An Annals of Oncology study of 20 female breast cancer patients suggests taxane chemotherapy drugs, such as Taxotere, “seem to be responsible for [severe and permanent female hair loss].” Researchers ruled out other potential factors that can lead to female alopecia, including mineral deficiencies and excessive androgen.

In December 2015, the United States Food and Drug Administration (FDA) agreed with the research. The FDA’s Center for Drug Evaluation and Research (CDER) issued a Taxotere drug label update to warn doctors and patients of the potential for permanent alopecia.

Get Help With Your Taxotere® Hair Loss Lawsuit

After you’ve conquered cancer, permanent alopecia can be a harsh physical and psychological reminder of one of the most difficult times of your life. At Crumley Roberts, our lawyers want to hold the drug company accountable for what they’ve put you through. Don’t wait. Get the experienced representation you need if you’ve suffered permanent hair loss after taking Taxotere. Call 866-336-4547 or complete our free initial consultation form now.

Taxotere® is a registered trademark of sanofi-aventis U.S. LLC and is used here only to identify the product in question. This law firm is not associated with, sponsored by, or affiliated with Annals of Oncology, sanofi-aventis U.S. LLC, or the U.S. Food and Drug Administration.

Free Initial Consultation